Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effects of a GLP-1 agonist on satiety
hormones in patients with Prader-Willi Syndrome (genetic defect causing obesity).